Ketogenic Diets in Pancreatic Cancer and Associated Cachexia: Cellular Mechanisms and Clinical Perspectives

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive and extremely therapy-resistant cancer. It is estimated that up to 80% of PDAC patients present with cachexia, a multifactorial disorder characterized by the involuntary and ongoing wasting of skeletal muscle that affects therapeutic response...

Descripción completa

Detalles Bibliográficos
Autores principales: Cortez, Natalia E., Mackenzie, Gerardo G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471358/
https://www.ncbi.nlm.nih.gov/pubmed/34579079
http://dx.doi.org/10.3390/nu13093202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471358/
https://www.ncbi.nlm.nih.gov/pubmed/34579079
http://dx.doi.org/10.3390/nu13093202

Ejemplares similares